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Abstract
House dust mite (HDM)-allergic asthma is driven by T helper 2 (Th2)
lymphocytes, but also innate immune cells control key aspects of the
disease. The precise function of innate natural killer (NK) cells during
the initiation and propagation of asthma has been very confusing, in
part because different, not entirely specific, strategies were used to
target these cells. We show that HDM inhalation rapidly led to the
accumulation of NK cells in the lung-draining lymph nodes and of
activated CD69+ NK cells in the bronchoalveolar lumen. However,
genetically engineered Ncr1-DTA or Ncr1-DTR mice that constitu-
tively or temporarily lack NK cells, still developed all key features of
acute or chronic HDM-driven asthma, such as bronchial hyperreac-
tivity, Th2 cytokine production, eosinophilia, mucus overproduction,
and Th2-dependent immunoglobulin serum titers. The same results
were obtained by administration of conventional NK1.1 or asialo-
GM1 NK cell-depleting antibodies, antibody-mediated blocking of
the NKG2D receptor, or genetic NKG2D deficiency. Thus, although NK
cells accumulate in allergen-challenged lungs, our findings compre-
hensively demonstrate that these cells are not required for HDM-
driven asthma in the mouse.
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Introduction
Asthma is a major and ever-increasing health problem that currently
affects 300 million people worldwide (Lambrecht & Hammad,
2017). Allergic asthma is a prototype of type 2 immunity,
orchestrated by an aberrant adaptive CD4+ T helper 2 (Th2) cell
immune response to airborne allergens such as house dust mite
(HDM). Th2 cells produce the cytokines IL-4, IL-5, IL-9, and IL-13,
which induce immunoglobulin E (IgE) production by B cells, eosino-
phil infiltration of the airways, basophil and mast cell activation,
and goblet cell hyperplasia and increased mucus production (Lam-
brecht & Hammad, 2014). The excessive inflammatory response
causes bronchial hyperreactivity (BHR) and creates breathing diffi-
culties. Although Th2 cells have historically been regarded as
central mediators, several innate immune cells are also critically
important in orchestrating various aspects of the allergic inflamma-
tory response in mouse models (Akbari et al, 2003; Sokol et al,
2008; Hammad et al, 2009, 2010; Nussbaum et al, 2013; Plantinga
et al, 2013; Halim et al, 2014; Schuijs et al, 2015).
Conventional natural killer (NK) cells are key components of
innate immunity, best known for their anti-viral and anti-tumor
activity. Moreover, NK cells are increasingly appreciated to play a
regulatory role in the immune system, being capable of influencing
DC functions (Degli-Esposti & Smyth, 2005; Walzer et al, 2005;
Moretta et al, 2006), shaping CD8+ T cell memory responses
(Soderquest et al, 2011; Crouse et al, 2014; Xu et al, 2014), and
promoting CD4+ Th1 cell polarization (Martı´n-Fontecha et al, 2004;
Morandi et al, 2006; Lu et al, 2007). Under certain conditions, NK
cells can even secrete Th2 cytokines, and thereby might promote or
enhance type 2 immunity (Warren et al, 1995; Walker et al, 1998;
Cooper et al, 2011).
NK cells are ubiquitously present in human and mouse lungs,
where they comprise 10–15% of resident lymphocytes (Gregoire
et al, 2007; Marquardt et al, 2017). Therefore, many studies have
aimed at elucidating their role in allergic asthma. Initial studies have
used NK1.1 or asialo-GM1 (ASGM1) depleting antibodies (Korsgren
et al, 1999; Ple et al, 2010), or mice genetically deficient for the acti-
vating receptor NKp46 (Ghadially et al, 2013) or NKG2D (Farhadi
et al, 2014). These studies showed that NK cells were crucial and
non-redundant for asthma development induced by ovalbumin
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(OVA)/alum (Korsgren et al, 1999; Ple et al, 2010; Ghadially et al,
2013) or chronic HDM exposure (Farhadi et al, 2014). In contrast,
increased pulmonary NK cell numbers were recently correlated with
reduced HDM-mediated airway inflammation in mice (Ferrini et al,
2016; Simons et al, 2017). Moreover, antibody-mediated NK cell
depletion was shown to increase eosinophilia and goblet cell hyper-
plasia in early papain- or bleomycin-induced lung inflammation
(Wan Jiacheng Bi et al, 2017). Overall, results on the role of NK
cells in experimental asthma are thus conflicting, model-dependent,
and, most importantly, have not used the same tools for NK cell
depletion or alteration of function.
To definitively address the role of NK cells in HDM-driven aller-
gic asthma, we here performed a comprehensive study using vari-
ous approaches to target or deplete NK cells in a well-established
HDM asthma model. In addition to conventional antibody-mediated
depletion techniques, we also included novel tools to genetically
deplete NKp46+ NK cells (Narni-Mancinelli et al, 2011). Although
NK cells were activated in the bronchoalveolar lumen (BAL) of mice
exposed to HDM, constitutive or temporary genetic depletion of NK
cells did not reduce or enhance HDM-induced asthma features. This
was confirmed in a more chronic asthma model and using another
allergen. In our hands, also NKG2D-deficient mice developed
normal HDM-induced eosinophilia. Taken together, our findings
challenge earlier findings and show that NK cells play a minor role
in the development of HDM-induced allergic asthma.
Results
HDM allergen activates NK cells in selected compartments
We first analyzed the impact of HDM exposure on NK cell numbers
and activation in the lung interstitium, bronchoalveolar lumen
accessible by lavage (BAL), and lung-draining mediastinal lymph
nodes (MLNs). C57Bl/6 mice received an intratracheal (i.t.) instilla-
tion of a high dose of crude HDM extract, known to induce an
innate immune response (Hammad et al, 2010), and NK cell
responses were assessed over time (Fig 1A). In naı¨ve mice, very few
NK cells were located in BAL and MLNs (Fig 1B–D). From day 0.5
after HDM exposure, NK cells were easily detectable in both organs
and numbers peaked at day 1.5, followed by a rapid decline. The
expression of the activation marker CD69 on BAL, but not MLN, NK
cells increased over time, suggesting an enhanced activation state
(Fig 1F and G). In lung tissue from which circulating blood cells
were flushed out, NK cell numbers were substantial in naı¨ve mice
(Fig 1B and E), consistent with earlier reports (Gregoire et al,
2007), and were not significantly influenced by HDM instillation.
Lung NK cells did, however, temporarily gain some CD69 expres-
sion (Fig 1H). Thus, HDM instillation resulted in a temporary infil-
tration and activation of NK cells in various anatomical regions of
the pulmonary immune system, including the inductive MLN site.
Absence of NKp46+ cells does not affect allergic asthma induced
by several models
Several studies have been performed to address the role of NK cells
in allergic asthma, using various markers to target or deplete NK
cells (Korsgren et al, 1999; Ple et al, 2010; Ghadially et al, 2013;
Farhadi et al, 2014). Some of these markers are also expressed by
subsets of T cells in various inflammatory conditions (Slifka et al,
2000). Since activated CD4+ T cells are key players in allergic
asthma, we determined the specificity of expression of NKp46,
NKG2D, ASGM1, and NK1.1 on NK cells, NK1.1+ natural killer T
(NKT) cells, and naı¨ve and memory conventional CD4+ T cells in
the lungs of naı¨ve and asthmatic mice (Fig 2A and B). NKp46 was
expressed on all NK cells, and a minor subset of NK1.1+ NKT cells,
as previously reported (Walzer et al, 2007; Yu et al, 2011), whereas
expression on naı¨ve or memory T cells was absent in both groups of
mice (Fig 2C). NK1.1, NKG2D, and ASGM1 were all highly
expressed on NK cells, and particularly NK1.1 and NKG2D were also
highly expressed on most NK1.1+ NKT cells. Thus, to deplete NK
cells, NKp46 was first chosen based on its robust expression on all
NK cells and limited expression on other cell types relevant to
asthma.
ROSA-flox-stop-flox-diphtheria toxin A (ROSADTA/DTA) mice
were crossed to mice that express Cre recombinase driven by the
NKp46 promoter (Ncr1iCre/iCre) (Narni-Mancinelli et al, 2011; Deau-
vieau et al, 2016). ROSADTA/+ Ncr1iCre/+ mice, called NKp46-DTA
hereafter, were confirmed to lack NKp46+ NK1.1+ CD3 cells in
all investigated organs (Fig EV1A). These cells include bone fide
NK cells, but also subsets of innate lymphoid cells (ILCs) type 1
(ILC1s) and ILC3s (Cella et al, 2009; Luci et al, 2009; Sanos et al,
2009; Cortez & Colonna, 2016). NKp46-DTA mice, and their litter-
mate controls (ROSA+/+ Ncr1iCre/+), were i.t. sensitized to HDM
and subsequently challenged with intranasal (i.n.) HDM inocula-
tions on five repetitive days (Fig 3A). NKp46-DTA mice lacked NK
cells in BAL (Fig 3B). HDM-sensitized, but not mock-sensitized,
littermate mice exhibited strong bronchial hyperreactivity (BHR) in
response to increasing doses of methacholine, and this response
was also seen in NKp46-DTA mice (Fig 3C). In both littermate
control and NKp46-DTA mice, HDM sensitization induced peri-
bronchial and perivascular influx of immune cells in the lungs
(Fig 3D), increased mucus production (Fig 3D), and eosinophil, B
cell, and T cell infiltration in the BAL (Fig 3E), hallmarks of type
2 immunity. Moreover, serum levels of Th2-associated HDM-
specific immunoglobulins E (IgE) and IgG1 were not affected by
NKp46+ cell absence (Fig 3F). The induction of eosinophilia and
goblet cell metaplasia depends on IL-5 and IL-13, respectively. We
therefore measured the presence of these key Th2 cytokines in
total lung tissue, and their production by HDM-restimulated MLN
cells. The levels of these and other cytokines (IL-10, IL-17, IFN-c)
were comparable between NKp46-DTA and littermate mice (Fig 3G
and H).
Additionally, the response of NKp46-DTA mice was assessed in a
more chronic HDM-driven model, adapted from Johnson et al
(2004) and Gregory et al (2009), in which the mice were adminis-
tered 25 lg HDM i.n. three times a week, for 3 weeks (Fig 4A and
B). Again, the absence of NKp46+ cells did not significantly influ-
ence cardinal features of HDM-driven asthma (Fig 4C–E), although
there was a trend toward lower HDM-specific IgG1 serum levels in
NKp46-DTA mice. These findings contrast with earlier studies in
OVA/alum-based allergic asthma models (Korsgren et al, 1999; Ple
et al, 2010; Ghadially et al, 2013). To exclude allergen-dependency,
littermate and NKp46-DTA mice were subjected to an OVA/alum-
based allergic asthma model (Fig 4F and G). Again, we found that
inflammatory cell infiltration in BAL upon OVA/alum-induced
EMBO Molecular Medicine e8657 | 2018 ª 2018 The Authors
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asthma was comparable between littermate and NKp46-DTA mice
(Fig 4H). Taken together, NKp46-DTA and littermate control mice
displayed a very similar Th2-mediated asthmatic response to HDM
or OVA.
Cardinal features of HDM-induced allergic asthma are not
influenced by NKp46+ cell absence during the sensitization or
challenge phase only
In NKp46-DTA mice, ablation of NKp46+ NK cells occurs early
during their maturation in the bone marrow (Narni-Mancinelli et al,
2011), raising the possibility of functional replacement of NK cells by
other immune cell types during immune development. Moreover,
previous studies have suggested that NK cells can fulfill opposing
roles during asthma, depending on the models used (Korsgren et al,
1999; Ple et al, 2010; Ghadially et al, 2013; Farhadi et al, 2014;
Ferrini et al, 2016; Simons et al, 2017; Wan Jiacheng Bi et al, 2017).
We therefore considered the possibility that NK cells might have
contrasting roles in the sensitization and challenge phase of the
HDM-induced asthma model, which might be obscured in animals
constitutively lacking NK cells. The influence of these two hypotheses
was investigated by crossing Ncr1iCre/iCre mice to ROSA-stop-flox-
stop-diphtheria toxin receptor (ROSADTR/DTR) mice (Narni-Mancinelli
et al, 2011), generating a model of inducible and temporary NK cell
depletion. DT injection efficiently depleted pulmonary NK cells in
ROSADTR/+ Ncr1iCre/+ mice, called NKp46-DTR hereafter, but not in
DTR-negative (ROSA+/+ Ncr1iCre/+) littermate mice, and the cells
remained absent for at least 4 days (Fig EV1B and C).
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Figure 1. Pulmonary HDM exposure leads to infiltration of NK cells in bronchoalveolar lavage fluid (BAL) and mediastinal lymph nodes (MLNs).
A Eight-week-old female C57Bl/6J mice were administered 100 lg HDM intratracheally. BAL, MLNs, and lung tissue were harvested on indicated time points for
analysis by flow cytometry.
B NK cell infiltration in BAL, MLN single-cell suspensions, and homogenized lung tissue, pre-gated on live CD45+ single cells. One representative plot is shown for
each condition, and percentage of NK cells (live, CD45+CD3/19-Nkp46+) of live CD45+ cells is indicated.
C–E Quantification of NK cell infiltration in BAL (C), MLN cell suspensions (D), and homogenized lung tissue (E).
F–H Mean fluorescence intensity (MFI) of activation marker CD69 on NK cells.
Data information: Data were analyzed with an unpaired Kruskal–Wallis test without multiple comparison correction, and individual data points are shown  SEM..
N = 5 mice for D0 and 4 for other time points. Results are representative of at least two independently performed experiments. **P < 0.01; ***P < 0.001 compared to
day 0. $P < 0.05; $$P < 0.01; $$$P < 0.001 compared to day 0.5. All exact P-values are presented in Table EV1.
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To investigate the role of NKp46+ cells during the allergic sensiti-
zation phase, NKp46-DTR mice and littermate controls were treated
with DT before HDM sensitization, or NKp46-DTR mice were mock-
treated with PBS, as an additional control (Fig 5A). NK cell depletion
was confirmed non-invasively on blood samples (Fig 5C). NK cells
were then allowed to reconstitute, and the mice were challenged
with HDM 1 month after sensitization. All three groups of HDM-
sensitized and HDM-challenged mice showed similar eosinophil, B
cell, T cell, and neutrophil infiltration in the BAL (Fig 5B), and
HDM-specific IgE and IgG1 levels in serum (Fig 5E). Similarly, MLN
cells harvested from DT-treated and control PBS-treated NKp46-DTR
mice produced comparable amounts of Th2 cytokines after HDM
restimulation (Fig 5D). Next, NKp46+ cell function during the chal-
lenge phase was studied by injecting DT just before and during the
HDM challenges (Fig 5F). Although this resulted in efficient NK cell
depletion (Fig 5H), it did neither abort nor exacerbate BAL eosino-
phil infiltration (Fig 5G), cytokine production by HDM-restimulated
MLN cells (Fig 5I), or HDM-specific IgE and IgG1 production
(Fig 5J). Finally, NKp46-DTR mice were treated with DT or PBS both
before HDM sensitization and before HDM challenges, and here
again, BAL immune cell infiltration was similar in the two groups of
HDM-sensitized and -challenged mice (Fig EV2A and B).
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Figure 2. NK cell marker expression on pulmonary T, NKT, and NK cells remains unchanged in response to HDM-mediated allergic asthma.
A C57Bl/6J mice were sensitized intratracheally on day 0 with 1 lg HDM or PBS, followed by five consecutive intranasal challenges with 10 lg HDM or PBS 7 days later.
Lungs were harvested and homogenized 4 days after the last challenge.
B Gating strategy for identification of NK cells, NK1.1+ NKT cells, and naïve (CD44) and memory (CD44+) CD4+ T cells.
C Representative histogram of NKp46, NK1.1, NKG2D, and asialo-GM1 expression on cell populations gated as in (B). Data are representative of two experiments with
each two to three mice per group. FMO = Fluorescence minus one.
▸Figure 3. Absence of NKp46+ cells does not reduce nor exacerbate hallmarks of HDM-induced allergic asthma.A On indicated time points, mice deficient of NKp46+ cells (NKp46-DTA, Ncr1iCre/+ ROSADTA/+) and littermate controls (Ncr1iCre/+ ROSA+/+) were sensitized intratracheally
with 1 lg HDM, or mock-sensitized with PBS, followed by five consecutive intranasal challenges with 10 lg HDM. 3–4 days later, bronchial hyperreactivity (BHR)
was measured (C) or organs were harvested for analysis (B, D–G). Alternatively, lung tissue was harvested 3 h after the 4th challenge on day 10 (H).
B NK cell (live, TCR-b NK1.1+ CD122+) numbers in BAL, assessed by flow cytometry. n = 7 (a, b) or 6 (c, d).
C Airway resistance in response to increasing doses of methacholine (Mch). Data are pooled from two independent experiments, with total n = 7 (a), 14 (b), 7 (c) and 15
(d). *P = 0.0348; **P = 0.0058 for dose 400 mg/ml Mch compared to mock-sensitized control group (d to c and b to a, respectively).
D Detection of mucus production by periodic acid–Schiff (PAS) staining on OCT-inflated lung cryosections.
E Infiltration of eosinophils, neutrophils, B cells, and T cells to BAL, assessed by flow cytometry. Data are pooled from four independent experiments with total n = 17
(a), 28 (b), 19 (c), and 26 (d).
F HDM-specific immunoglobulin serum levels, detected by ELISA. Data are pooled from three independent experiments with total n = 13 (a), 21 (b), 17 (c), and 20 (d).
G MLN single-cell suspensions were restimulated with 15 lg/ml HDM for 3 days, and cytokine production was measured by ELISA. Data are representative of four
independent experiments. n = 7 (a, b) or 6 (c, d).
H Snap-frozen lung tissue was homogenized and analyzed for cytokine levels by ELISA, and for total protein content by NanoOrange technology. Results are depicted as
pg cytokine/mg total protein. n = 5 (a, c) or 6 (b, d).
Data information: All data were analyzed with an unpaired Kruskal–Wallis test without multiple comparison correction and are shown as means  SEM. *P < 0.05;
**P < 0.01; ***P < 0.001; ****P < 0.0001. Exact P-values are presented in Table EV1.
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Targeting NK cells with other (depletion) techniques does not
affect HDM-induced allergic asthma
To facilitate a careful comparison with earlier studies, which
utilized NK cell-depleting antibodies, we treated C57Bl/6 wild-type
mice with anti-NK1.1 or anti-ASGM1 depleting antibodies, anti-
NKG2D blocking antibodies, anti-b-galactosidase antibodies as a
control, or anti-CD4 antibodies to deplete CD4+ T cells as an addi-
tional control (Fig 6A). Anti-NKG2D blocking antibody efficiently
blocked NKG2D surface expression on splenic NK cells for at least
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7 days (Fig EV3A and B). As depleted NK cells start to reconstitute
after 4 days (Fig EV1A), all antibodies were administered every 3–
4 days. NKG2D blocking or complete NK cell absence was again
confirmed in the lungs at the time of sacrifice (Fig EV3C–F).
Whereas CD4+ T cell depletion completely aborted influx of eosino-
phils in the BAL, administration of the other antibodies did not
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Figure 4. Absence of NKp46+ cells does not lead to a significant reduction in asthma hallmarks in response to chronic HDM exposure or OVA/alum-induced
allergic asthma.
A Mice deficient of NKp46+ cells (NKp46-DTA, Ncr1iCre/+ ROSADTA/+) and littermates (Ncr1iCre/+ ROSA+/+) were intranasally challenged with 25 lg HDM three times a week
for 3 weeks, or mock-challenged with PBS, and analyzed 24 h after the last challenge (B–E).
B NK cell (live, TCR-b NK1.1+ CD122+) absence was confirmed by flow cytometry on spleen cells.
C Infiltration of eosinophils, neutrophils, B cells, and T cells in BAL, assessed by flow cytometry.
D MLN single-cell suspensions were restimulated with 15 lg/ml HDM for 3 days, and cytokine production was measured by ELISA.
E HDM-specific immunoglobulin serum levels, detected by ELISA.
F On indicated time points, NKp46-DTA mice and littermates intraperitoneally (i.p.) received 10 lg OVA absorbed on 1 mg alum (or OVA without alum as control), an
i.p. boost of 10 lg OVA, and three intranasal OVA challenges (20 lg). Parameters were analyzed 24 h after the last challenge (G, H).
G NK cell (live, TCR-b NK1.1+ CD122+) absence was confirmed by flow cytometry on spleen cells.
H Infiltration of eosinophils, neutrophils, B cells, and T cells in BAL, assessed by flow cytometry.
Data information: Data in (B–E) are pooled from two independent experiments with total n = 6 for mock-sensitized groups and total n = 14 for HDM-sensitized groups.
Data in (G, H): n = 4 for mock-sensitized and n = 7 for OVA/alum-sensitized groups. Data were analyzed with an unpaired Kruskal–Wallis test without multiple
comparison correction and are shown as means  SEM. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. $P < 0.05; $$P < 0.01; $$$P < 0.001 compared to both
littermate groups. Exact P-values are presented in Table EV1.
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Figure 5. Induced absence of NKp46+ cells during the sensitization or challenge phase of HDM-mediated allergic asthma does not influence asthma
hallmarks.
A–J (A, F) C57Bl/6 NKp46-DTR mice (Ncr1iCre/+ ROSADTR/+) or littermate controls (Ncr1iCre/+ ROSA+/+) were sensitized intratracheally on day 0 with 1 lg HDM, or mock-
sensitized with PBS. Four weeks (A) or 10 days (F) later, they were intranasally challenged on five consecutive days with 10 lg HDM. DT was injected at indicated
time points, to deplete NKp46+ cells during the sensitization (A) or challenge (F) phase. Hallmarks of asthma were studied 3–4 days after the last challenge and
shown in (B–E) and (G–J), respectively. (C, H) NK cell (live, TCR-b NK1.1+ CD122+) depletion was confirmed by flow cytometry on spleen cells. (B, G) Infiltration of
eosinophils, neutrophils, B cells, and T cells in BAL, determined by flow cytometry. (D, I) MLN single-cell suspensions were restimulated with 15 lg/ml HDM for
3 days, and cytokine production was measured by ELISA. (E, J) HDM-specific immunoglobulin serum levels, detected by ELISA.
Data information: In (B, C, and E), n = 3 (c, e), 5 (f) or 6 (a, b, d); in (G, H, and J), n = 3 (e) or 4 (a, b, d, f); in (D and I), n = 5. BAL data are representative of two
independently performed experiments. Data were analyzed with an unpaired Kruskal–Wallis test without multiple comparison correction, or with an unpaired Mann–
Whitney test for (D and I), and are shown as means  SEM. *P < 0.05; **P < 0.01; ****P < 0.0001; $P < 0.05; $$P < 0.01 for ≥ 2 control groups. All exact P-values are
presented in Table EV1.
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inhibit asthma hallmarks (Fig 6B–D). There was a trend for higher
inflammatory cell influx in anti-ASGM1-treated animals, but this
failed to reach statistical significance. Moreover, administration of
anti-NK1.1 or anti-NKG2D also did not alter cardinal features of
allergic asthma induced by the chronic HDM-based asthma model
(Fig EV4A–C). The finding that administration of anti-NKG2D does
not inhibit HDM-mediated allergic asthma contrasts with earlier
research that used mice genetically deficient for NKG2D (Klrk1/)
(Farhadi et al, 2014). Accurate comparison of these results might be
hampered by some undesirable side effects of antibody injection,
such as nonspecific binding to Fc receptors, or surface receptor
cross-linking followed by cell activation (Arase et al, 1997). To elim-
inate confusion from these side effects, Klrk1/ mice and littermate
controls were subjected to HDM-induced asthma (Fig 7A and B).
This resulted in substantial and comparable HDM-specific IgE and
IgG1 serum levels (Fig 7C), infiltration of eosinophils and other
immune cells in the BAL (Fig 7D), and Th2 cytokine production by
HDM-restimulated MLN cells (Fig 7E), in both NKG2D-deficient and
littermate mice. Finally, genetic absence of NKG2D had no impact
on BAL eosinophilia, Th2 cytokine production, or IgE and IgG1
serum levels in response to chronic HDM exposure (Fig EV5A–E).
Discussion
In this study, we comprehensively addressed the long-held hypothe-
sis that NK cells play an important role in asthma. Using the most
advanced method to genetically deplete NKp46+ NK cells, we found
no support for this hypothesis. Therefore, the claim of a true null
hypothesis (NK cells do not play a critical role in asthma) was further
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Figure 6. HDM-induced allergic asthma is not influenced by antibody-mediated depletion of NK cells or NKG2D blocking on NK cells.
A C57Bl/6J WT mice were sensitized intratracheally on day 0 with 1 lg HDM, or mock-sensitized with PBS, followed after 1 week by five consecutive intranasal
challenges with 10 lg HDM. From day 1, NK cell-depleting anti-NK1.1 or anti-ASGM1, NKG2D-blocking anti-NKG2D, CD4+ T cell-depleting anti-CD4, or control
anti-b-galactosidase antibodies were administered intraperitoneally every 3–4 days. Mice were analyzed 4 days after the last HDM challenge.
B, C Infiltration of eosinophils, B cells, T cells, and neutrophils in BAL, assessed by flow cytometry. Data are pooled from two independently performed experiments with
total n = 6 (a, e), 10 (c), 11 (b) or 12 (d) in (B) and total n = 11 (a), 12 (f) or 13 (b) in (C).
D MLN single-cell suspensions were restimulated with 15 lg/ml HDM for 3 days to measure cytokine production in culture medium by ELISA. N = 6 mice per group.
Data information: Data were analyzed with an unpaired Kruskal–Wallis test without multiple comparison correction and are shown as means  SEM. *P < 0.05;
**P < 0.01; ***P < 0.001; ****P < 0.0001 compared to b-gal—PBS. $P < 0.01; $$P < 0.001 compared to a-CD4—HDM. All exact P-values are presented in Table EV1.
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substantiated. NK cells were depleted during asthma development by
the administration of conventional NK cell-depleting antibodies. NK
cells were also temporarily depleted during the separate phases of
asthma development (sensitization and challenge), eliminating the
possibility that the role of NK cells during these phases might be
opposite. To address any potential confounding bias due to the type
of animal model used, NK cells were depleted in an OVA/alum-based
model and a more chronic HDM-driven model. Finally, as cellular
depletion could not be the best option to reveal a role for NK cells,
we interfered with NK cell function rather than numbers by blocking
the prototypic NK cell-activating NKG2D receptor using antibodies or
genetic NKG2D deficiency. As none of these intervention strategies
affected asthma severity, we accept the null hypothesis that NK cells
are dispensable for allergic asthma development in mice.
NKp46 is not entirely specific for NK cells and is also expressed on
Eomes+ ILC1s in salivary glands, Eomes ILC1s in liver, skin, and peri-
toneum, and a subset of IL-22 producing ROR-ct+ ILC3s in the gut
(Cella et al, 2009; Luci et al, 2009; Sanos et al, 2009; Cortez & Colonna,
2016). These populations are very rare in the lungs of naive mice, but
the ILC1 population could potentially expand in inflamed tissues, as
was shown for CD127+ ILC1-like cells in the spleens of chronically
infected mice (Gasteiger et al, 2013). Additionally, NKp46 expression
has been detected on a subset of non-CD1d restricted NK1.1+ NKT
cells (Walzer et al, 2007; Yu et al, 2011) and a subset of cdT cells (Ste-
wart et al, 2007). Our data suggest that all these cell (sub)populations
are also dispensable for HDM-mediated asthma development.
Our findings are in marked contrast to earlier studies that have
relied on targeting NK1.1, ASGM1, or NKG2D (Korsgren et al,
1999; Ple et al, 2010; Ghadially et al, 2013; Farhadi et al, 2014),
none of which are unique for NK cells. NK1.1 is expressed on
both NK and NKT cells, the latter possibly being able to modulate
airway disease (Akbari et al, 2003; Berzins & Ritchie, 2014), and
on some virus-specific CD4+ and CD8+ T cells (Slifka et al,
2000). ASGM1 has been detected on the majority of, but not all,
murine NK cells, subsets of CD8+ T cells, basophils, and in some
instances even on eosinophils or activated CD4+ T cells (Tramb-
ley et al, 1999; Slifka et al, 2000; Kataoka et al, 2004; Nishikado
et al, 2011). We demonstrated NKG2D expression on NK cells,
but also on activated CD44+ CD4+ T cells, albeit to a lesser
extent. Moreover, NKG2D expression was detected on NKT cells,
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Figure 7. Absence of NKG2D surface expression does not influence HDM-induced allergic asthma.
A C57Bl/6 NKG2D knockout mice (Klrk1/) or littermate controls were sensitized intratracheally on day 0 with 1 lg HDM, or mock-sensitized with PBS, followed after
1 week by five consecutive intranasal challenges with 10 lg HDM, and analysis 3 days after the last challenge.
B Mean fluorescence intensity (MFI) of NKG2D-APC on live splenic NK cells (CD3 NK1.1+ CD122+), assessed by flow cytometry.
C HDM-specific immunoglobulin serum levels, detected by ELISA.
D Infiltration of eosinophils, B cells, T cells, and neutrophils to BAL, determined using flow cytometry.
E MLN single-cell suspensions were restimulated with 15 lg/ml HDM for 3 days to measure cytokine production in culture medium by ELISA.
Data information: All data are pooled from two independent experiments with total n = 7 (a), 15 (b), 8 (c) or 14 (d). Data were analyzed with an unpaired Kruskal–Wallis
test without multiple comparison correction and are shown as means  SEM. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. $P < 0.001 compared to both
littermate groups. All exact P-values are presented in Table EV1.
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cdT cells, and CD8+ T cells (Bauer, 1999; Jamieson et al, 2002).
Nevertheless, in the two HDM models investigated here, depletion
of NK1.1- or ASGM1-expressing cells did not blunt allergic
inflammation, nor did the antibody-mediated blocking or genetic
removal of the activating NKG2D receptor. Therefore, this study
excludes differences in experimental techniques as an explanation
for conflicting results and affirms our conclusions across several
models of NK cell depletion or targeting.
Recently, interactions between NK cells and ILC2s have been
demonstrated in HDM-induced allergic asthma, in which NK cells
play an anti-inflammatory role (Ferrini et al, 2016; Simons et al,
2017). The absence of the eicosanoid CB2 or PGI2 receptor
resulted in increased NK cell numbers in BAL, indirectly
affecting ILC2s numbers and activity, and impediment of asthma
development. By means of transfer studies, this was validated to
be NK cell dependent. Notably, this anti-inflammatory role of NK
cells was only observed in conditions where NK cells were
strongly increased in number and possibly differentially acti-
vated. Indeed, WT mice, harboring physiological amounts of
pulmonary NK cells, were perfectly able to develop inflammation
upon HDM instillation, and anti-NK1.1 antibody treatment in
these mice caused only a modest increase in total BAL cell
numbers without influencing other investigated asthma hallmarks
(Ferrini et al, 2016; Simons et al, 2017). Interestingly, the rare
human NK cell deficiencies described in literature have not yet
been associated with hypersensitivity reactions (Voss & Bryceson,
2017). Although the authors justly state that modulating NK cell
function provides a promising therapeutic strategy, we here show
that NK cells, when present in the physiological amounts and
activation state imposed by HDM exposure, have negligible anti-
inflammatory capacities.
Interestingly, none of the studies that demonstrated a pro-inflam-
matory function of NK cells mentioned the pathogen status of their
animal facility. Our mouse studies were performed in specific
pathogen free (SPF)-housed animals. Differences in housing condi-
tions could potentially have an impact on gut microbiome diversity,
which, in humans, has been shown to correlate with increased risk
of atopic eczema or allergic asthma (Bisgaard et al, 2011; Abra-
hamsson et al, 2012). The risk of allergen sensitization might also
directly be influenced by housing conditions; we previously showed
that exposure to minute amounts of LPS or farm dust drastically
blunted the allergic airway response, due to desensitization of the
airway epithelium (Schuijs et al, 2015). Moreover, mice fed a high-
fiber diet had a changed composition of gut and lung microbiome
and were protected from allergic asthma development (Trompette
et al, 2014). Therefore, the threshold for allergic sensitization could
be increased in animal facilities in which animals have a different
microbiome composition or are fed a different animal chow, or in
which some pathogens are allowed to persist. This may then possi-
bly necessitate additional innate signals, such as those delivered by
NK cells, to develop a full-blown allergic response.
In summary, by using the newest genetic tools, we demonstrate
that NK cells play a minor role in the establishment of HDM-induced
allergic asthma. In the future, we have to more comprehensively
assess the impact of environmental conditions and microbiome on
the function of NK cells in asthma. Only then, we will be able to
model and grasp the full therapeutic potential of these cells in
human asthma.
Materials and Methods
Mice
Ncr1iCre/iCre mice were previously described (Narni-Mancinelli
et al, 2011). ROSADTA/DTA, ROSADTR/DTR, and Klrk1/ (Guerra
et al, 2008) mice were obtained from The Jackson Laboratory.
C57Bl/6J wild-type mice were obtained from Janvier. All mice
were on a C57Bl/6 genetic background and 6–10 weeks old. As
differences in male and female mice were not observed, both
sexes were used and the mice were first age- and sex-matched,
then randomly assigned per group and per experiment, without
specific randomization procedure. Mice were housed and bred at
the specific pathogen free (SPF) facility of VIB-University of
Ghent, in individually ventilated cages with a controlled day–
night cycle and given food and water ad libitum. Experiments
conform to the Belgian laws and regulations concerning the use
of animals for research and were approved by the Animal Ethical
Committees of the University of Ghent and the Center of
Inflammation Research.
Models of allergic asthma
NK cell kinetics following HDM exposure were investigated by i.t.
instilling mice with 100 lg HDM. Acute HDM-induced allergic
inflammation was established by i.t. sensitization with 1 lg HDM
extract (Greer Laboratories), or with PBS as a control (day 0),
followed by five consecutive i.n. challenges with 10 lg HDM (days
7–11). Asthma features were analyzed 3 or 4 days later. In the
chronic HDM-induced asthma model adapted from (Johnson et al,
2004; Gregory et al, 2009), mice were instilled i.n. with 25 lg HDM,
or PBS as a control, three times a week for 3 weeks. Asthma
features were determined 24 h after the last challenge. OVA-
mediated asthma was induced by an i.p. injection of 10 lg purified
OVA (Worthington) absorbed on 1 mg alum (day 0), a boost i.p.
injection of 10 lg purified OVA (day 7), and subsequent i.n. chal-
lenges on days 17–19 with 20 lg OVA. Asthma features were deter-
mined 24 h after the last challenge. All i.t. and i.n. treatments were
given in 80 and 40 ll PBS, respectively, and under light isoflurane
anesthesia.
In vivo ablation of cells or blocking of NKG2D
To deplete NKp46+ cells in ROSADTR/+ Ncr1iCre/+ mice, 200 ng DT
(Sigma) was injected intravenously at indicated time points. For
antibody-mediated depletion or blocking studies, mice were i.p.
administered 200 lg of antibodies, diluted in PBS, every 3–4 days,
starting at day 1. Anti-NKG2D (CX5), anti-CD4 (GK1.5), anti-
NK1.1 (PK136), and control anti-b-galactosidase (GL113) antibodies
were produced by Bioceros. Anti-ASGM1 was purchased from Wako
and 50 ll of reconstituted (in 1 ml dH2O) antibodies were adminis-
tered, diluted in PBS.
Effector cytokine production
Dissected MLNs were pressed through a 100-lM cell sieve. The
acquired single-cell suspensions were seeded (2 × 106 cells/ml) in
96-well plates in RPMI-1640 medium supplemented with 5% fetal
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calf serum (Bodinco), 0.1% b-mercaptoethanol, glutamax (Gibco)
and gentamycin (Gibco), and restimulated with 15 lg/ml HDM for
3 days. Snap-frozen total lungs were homogenized in a tissue Lyser
II device (Qiagen) for 4 min at 20 Hz, in 20% glycerol in dH2O with
40 mM Tris–HCl, 275 mM NaCl, and an EasyPack complete ULTRA-
tablet mini (Roche). 2% Igepal CA-630 (US biologicals) was added,
and homogenates were rotated for 30 min and then centrifuged.
MLN culture and homogenized lung tissue supernatants were
analyzed for cytokine levels by ELISA (Ready-set-go kits from eBio-
science), and for total protein concentration with NanoOrange tech-
nology (Thermo Fisher, Invitrogen).
Immunoglobulin production
Mice were bled under terminal anesthesia, and serum was collected
by centrifugal phase separation to determine IgE and IgG1 levels by
ELISA (BD Biosciences). For HDM-specific IgG1, ELISA plates were
coated with 100 lg/ml HDM (Greer Laboratories); For HDM-specific
IgE, the supplemented detection antibody was interchanged for
biotin-labeled HDM (100 lg/ml), diluted in PBS + 10% FCS.
Flow cytometry
Bronchoalveolar lumen fluid was obtained by flushing the lungs
with EDTA-containing PBS (0.5 mM) via a cannula inserted in the
trachea. Spleens and MLNs were dissected and pressed through a
100-lM cell sieve. Bones were crushed with mortar and pestle in
RPMI-1640 medium and filtered through a 70-lM cell sieve. Whole
lungs were isolated in RPMI-1640 medium supplemented with
DNAse I recombinant Grade I (10 U/ml) and Liberase TM (20 lg/
ml), both purchased from Roche. Lung tissue was dissociated using
the GentleMACS (Miltenyi Biotec) lung programs 1 and 2, with
gentle shaking at 37°C for 30 min in between both steps. The reac-
tion was stopped by adding excess PBS, and the obtained single-cell
suspensions were filtered through a 100-lm sieve. Cell suspensions
were treated with osmotic lysis buffer, stained with antibody cock-
tails in PBS for 30 min at 4°C, and subsequently washed in PBS
supplemented with 2 mM EDTA, 0.5% BSA, and 0.01% sodium
azide. Unspecific antibody binding was prevented by adding 2.4G2
(antibody to the Fcc receptor II/III) during the staining. Dead cells
were excluded by adding fixable viability dye conjugated to eFluor506
(eBioscience). A fixed amount of counting beads (123count ebeads,
Thermo Fisher Scientific) was added to determine absolute cell
numbers. Antibodies used for flow cytometry are summarized in
Table EV2. Samples were acquired on a LSRFortessa (4 laser, BD
Biosciences) and analyzed using Flowjo Software (Tree Star, Inc).
In BAL, eosinophils were gated as CD11c- CD3/19- Ly6G- CD11bhi
SiglecFhi SSC-Ahi, neutrophils as CD11c- CD3/19- Ly6Ghi CD11bhi,
B cells as CD11c- CD3/19hi MHC-IIhi and T cells as CD11c- CD3/
19hi MHC-II.
Mucus production
Lungs were inflated with 1 ml PBS/OCT (1:1) solution (Tissue-
Tek), snap-frozen in liquid nitrogen, and cryosectioned (7 lm)
using the HM560 microtome (Thermo Scientific) for PAS staining.
Pictures were obtained with AnalySIS getIT (Olympus Soft Imaging
Solutions).
BHR determination
Mice were anesthetized with urethane, paralyzed with D-tubocur-
arine, tracheotomized, and intubated with a 28-G catheter, followed
by mechanical ventilation in a Flexivant apparatus (SCIREQ). Respi-
ratory frequency was set at 150 breaths/min with a tidal volume of
10 ml/kg, and a positive-end expiratory pressure of 3 cm H2O was
applied. Increasing concentrations of methacholine were nebulized
(0–400 mg/ml); baseline resistance was restored in between the
doses. A standardized inhalation maneuver was given every 10 s for
2 min per dose, and dynamic resistance and compliance were
recorded.
Statistics
Sample sizes (n) represent the number of independent biological
replicates and were chosen according to previous experience with
the used experimental asthma models. Investigators were not
blinded during the experiments and/or analyses. The differences
between two, or more, groups were calculated with the Mann–Whit-
ney U-test for unpaired data, or the Kruskal–Wallis test for unpaired
data, respectively, without multiple comparison correction
(GraphPad Prism version 7.0; GraphPad, San Diego, CA). These
non-parametric statistical tests were chosen because data were not
The paper explained
Problem
Allergic asthma is a major health problem that currently affects
300 million people worldwide. A thorough understanding of the
underlying pathogenesis is key to the development of curing thera-
pies. Asthma is mainly driven by T helper 2 lymphocytes, but several
cells of the innate immune system also control key aspects of the
disease. The role of conventional natural killer (NK) cells, however,
remains elusive. Although NK cells have been proposed as a suitable
target for asthma therapy, murine studies on their function in asthma
are conflicting, in part because different, not entirely specific, tools
have been employed to deplete NK cells or target their function.
Results
In mice that were given inhaled house dust mite, a clinically relevant
allergen, NK cells migrated to the lungs and lung-draining lymph
nodes. However, Ncr1-DTA mice, which are genetically engineered to
lack all NK cells in the most specific way to date, still robustly devel-
oped all asthma symptoms upon acute or chronic house dust mite
exposure. Temporary depletion of NK cells during separate phases of
asthma development in Ncr1-DTR mice also had no impact on the
inflammatory phenotype. The results were additionally confirmed by
injecting conventional NK cell-depleting antibodies. Finally, antibody-
mediated blocking of the NK cell-activating NKG2D receptor, or
genetic NKG2D deficiency, did not alter asthma severity.
Impact
This study challenges earlier findings and demonstrates that NK cells
are not necessary for house dust mite-dependent asthma develop-
ment. It thus suggests that NK cells may not be the most robust and
all-encompassing therapeutic target to tackle allergic asthma. Alterna-
tively, it suggests that we may need a more comprehensive assess-
ment of the influence of environmental and microbial conditions on
the precise role of NK cells in asthma.
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normally distributed, and/or because normal distribution of the data
sets could not be assumed due to too small sample sizes and/or
unequal variance between experimental groups. Data are shown as
means  SEM, or as individual data points, where n < 5. N-values
and statistical tests used are mentioned in the figure legends; all
relevant P-values < 0.15 are depicted in the figures. All exact
P-values are represented in Table EV1.
Expanded View for this article is available online.
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